‘No risk, no fun’: Challenges for the oncology phase I clinical trial time-performance
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference31 articles.
1. Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT);Booth;Eur J Cancer,2008
2. Recommended changes to oncology clinical trial design: revolution or evolution?;Ratain;Eur J Cancer,2008
3. An open-label phase I dose escalation study of KRN951, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 1 in a 4 week on, 2 week off schedule in patients with advanced solid tumors;Eskens;J Clin Oncol,2006
4. Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience;Arkenau;Br J Cancer,2008
5. Clinical benefit in phase I trials of novel molecularly targeted agents: Does dose matter?;Postel-Vinay;J Clin Oncol,2008
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploratory Food Effect Assessment in Patients in Early Clinical Development of Oncology Drugs;Clinical Pharmacology & Therapeutics;2023-05-26
2. Determining the optimal dose in the development of anticancer agents;Nature Reviews Clinical Oncology;2014-03-25
3. Modifying phase I methodology to facilitate enrolment of molecularly selected patients;European Journal of Cancer;2013-05
4. Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer;Cancer Chemotherapy and Pharmacology;2012-07-01
5. Clinical trials in drug development;Current Opinion in Oncology;2012-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3